Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Reid

Showing results (211-220 of 250) with videos related to

Pageof 25
Sort By:
Pediatrics|September 1, 1991
Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacortJ Loftus, R Allen, R Hesp, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 7, 2011
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosisC Roux, D M Reid, J-P Devogelaer, et al.
Calcified Tissue International|October 3, 2003
Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in womenC Sobacchi, P Vezzoni, D M Reid, et al.
The American Journal of Clinical Nutrition|January 5, 2000
Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health?S A New, S P Robins, M K Campbell, et al.
Mucosal Immunology|September 10, 2015
CD4(+) T-cell survival in the GI tract requires dectin-1 during fungal infectionR A Drummond, I M Dambuza, S Vautier, et al.
The British Journal of Radiology|August 30, 2002
Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50 years of age: implications for clinical densitometryG Holt, K T Khaw, D M Reid, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 29, 2013
A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?A D Wood, K R Secombes, F Thies, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 23, 2010
Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57 degrees N and 51 degrees N: a longitudinal studyA Mavroeidi, F O'Neill, P A Lee, et al.
Calcified Tissue International|September 23, 2000
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapyS Wallach, S Cohen, D M Reid, et al.
International Journal of Clinical Practice|March 8, 2008
A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-InternationalD M Reid, D Hosking, D Kendler, et al.
Pageof 25

Showing results (211-220 of 250) with videos related to

Sort By:
Pageof 25
Pediatrics|September 1, 1991
Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacortJ Loftus, R Allen, R Hesp, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 7, 2011
Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosisC Roux, D M Reid, J-P Devogelaer, et al.
Calcified Tissue International|October 3, 2003
Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in womenC Sobacchi, P Vezzoni, D M Reid, et al.
The American Journal of Clinical Nutrition|January 5, 2000
Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health?S A New, S P Robins, M K Campbell, et al.
Mucosal Immunology|September 10, 2015
CD4(+) T-cell survival in the GI tract requires dectin-1 during fungal infectionR A Drummond, I M Dambuza, S Vautier, et al.
The British Journal of Radiology|August 30, 2002
Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50 years of age: implications for clinical densitometryG Holt, K T Khaw, D M Reid, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 29, 2013
A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?A D Wood, K R Secombes, F Thies, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 23, 2010
Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57 degrees N and 51 degrees N: a longitudinal studyA Mavroeidi, F O'Neill, P A Lee, et al.
Calcified Tissue International|September 23, 2000
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapyS Wallach, S Cohen, D M Reid, et al.
International Journal of Clinical Practice|March 8, 2008
A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24-month results from FACTS-InternationalD M Reid, D Hosking, D Kendler, et al.
Pageof 25